Abstract
The role of specific risk factors for Alzheimer’s disease (AD) is undefined. We compared medical histories in 259 patients with clinically diagnosed AD with those in cognitively intact patients (CI;n=36). The two groups were comparable in age (mean±SEM 73.3±0.6 in AD, 70.9 ±2.1 in CI), race (>95% white), and socioeconomic status, although they differed in male:female ratio (1:2 in AD; 1.6:1 in CI). Stroke was more common in CI (11.1% vs 1.5%, p=.006), presumably because demented patients with stroke tend to be diagnosed as multi-infarct dementia rather than AD. Family history for dementia was positive in 35.9% of AD patients, but only 5.6% of CI patients (p<0.001). Family history of other genetic disorders was more often positive in AD than in CI, but these differences were not statistically significant (thyroid disease in 1.5% vs 0%; Down’s in 0.8% vs 0%, and congenital malformations in 1.2% vs 0%). Other factors previously implicated in AD were not significantly more common in AD than in CI (head trauma in 4.2% vs 8.3%; peptic ulcers (presumably with aluminum-containing antacid use) in 5.8% vs 8.3%, alcoholism in 0.7% vs 0%, job-related toxic exposures in 1.5% vs 0%, and thyroid disease in 2.3% vs 0%). There were also no significant differences in prevalence of cancer; lung, biliary, or gastrointestinal disease; or arthritis. These data suggest that genetic factors are more important than environmental ones in the pathogenesis of AD, although case-control studies of large numbers of subjects are needed to determine if small differences in exposure to environmental factors are statistically significant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Larsson T, Sjogren T, Jacobson G: Senile dementia: a clinical, sociomedical, and genetic study. Acta Psychiatr. Scand (suppl.) 39. Supl. 167 (1963).
Heston LL, Mostri AR, Anderson VE, White J: Dementia of the Alzheimer type: clinical genetics, natural history and associated conditions. Arch. Gen. Psychiat. 38: 1085–1090 (1981).
H«yman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M: Alzheimer’s disease: genetic aspects and associated clinical disorders. Ann. Neurol. 14: 507–515 (1983).
Chase GA, Folstein MF, Breitner JCS, Beaty TH, Self SO: The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer’s disease. Am J. Epidemiol. 17: 590–597 (1983).
He St on LL. Mostri AR: The genetics of Alzheimer’s disease: associations with hematologic malignancy and Down syndrome. Arch. Gen. Psychiat. 34: 976–981 (1977).
Heston LL: Alzheimers disease, trisomy 21 and myeloproliferative disorders. Associations suggesting a genetic diathesis. Science 196: 322–323 (1977).s
Whalley LJ, Carothers AD, Collyer S, DeMey R, Frackiewicz: A study of familial factors in Alzheimer’s disease. Brit. J. Psychiat. 140: 249–256 (1982).
Heyman A. Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T: Alzheimer’s disease: a study of epidemiological aspects. Ann. Neurol. 15: 335–341 (1984).
Mikkel S: A cohort study of disability, pension, and death among workers with special regard to disabling presenile dementia as an occupational disease. Scand. J. Soc. Med. Suppl 16: 34 - 43 (1980).
Olsen J, Sabaroe S: A case reference study of neuropsychiatric disorders among workers exposed to solvents in the Danish wood and furniture industry. Scand. J. Soc. Med. Suppl 16: 44–49 (1980).
Crapper DR, Kushman SS, Quittkat S: Aluminum, neurofibrillary degeneration and Alzheimer’s disease. Brain 99: 67–80 (1976).
Trapp GA, Miner GD, Zimmerman RL, Mastri AR, Heston LL: Aluminum levels in brain in Alzheimer’s disease. Biol. Psychiat. 13: 709–718 (1978).
Zemcov A, Barclay LL, Brush D, Blass JP: Computerized data base for evaluation and follow-up of demented outpatients. J. Amer. Geriat. Soc. 32: 801–842 (1984),
Kahn RL, Goldfarb AI, Pollack MK, Peck A; Brief objective measures for the determination of mental status in the aged. Am. J. Psych. 117: 326–329 (1960).
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A: Pathological Verification of ischemic score in differentiation of dementias. Ann. Neurol. 7: 486–488 (1980).
Haycox JA: A simple reliable clinical behavioral scale for assessing demented patients. J. Clin. Psychiat. 45: 23–24, (1984).
McKahnn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease. Neurol 34: 939 - 944 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Barclay, L.L., Kheyfets, S., Zemcov, A., Blass, J.P., McDowell, F.H. (1986). Risk Factors in Alzheimer’s Disease. In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2179-8_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9283-8
Online ISBN: 978-1-4613-2179-8
eBook Packages: Springer Book Archive